<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01651572</url>
  </required_header>
  <id_info>
    <org_study_id>2633Pbis</org_study_id>
    <secondary_id>2012-002398-68</secondary_id>
    <secondary_id>CURARI_2012</secondary_id>
    <nct_id>NCT01651572</nct_id>
  </id_info>
  <brief_title>Comparison Between Cisatracurium and Rocuronium in Terms of Recovery of the Muscular Strength in the Postoperative Phase After Surgery and General Anaesthesia</brief_title>
  <official_title>Assessment of Post-operative Residual Curarization (PORC) Incidence in Patients Undergoing Surgery With General Anaesthesia; Comparison Between Cisatracurium and Rocuronium. A Randomised, Single-blind Phase 4 Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera di Padova</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera di Padova</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the incidence of post-operative residual
      curarization in our patients and to determine if Cisatracurium and Rocuronium behave
      differently from each other in terms of residual curarization.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of PORC</measure>
    <time_frame>Participants will be followed for the duration of their stay in the post-anaesthesia care unit (PACU), an expected average of 60 minutes.</time_frame>
    <description>To determine the incidence of post-operative residual curarization in our operating rooms, comparing two different neuromuscular-blocking agents: Cisatracurium and Rocuronium.
The primary endpoint is quantified with TOF-Ratio, determined with the device TOF-Watch SX (Organon, Netherlands). A TOF-Ratio&lt;0.90 defines PORC.
Three clinical parameters (head-tilt for 5 seconds, ability to swallow, presence of diplopia) are also evaluated.
TOF-Ratios, as long as the above-mentioned clinical parameters are determined and evaluated at 15, 30 and 60 minutes after extubation of the patient.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of PORC - comparison between Cisatracurium and Rocuronium</measure>
    <time_frame>Participants will be followed for the duration of their stay in the post-anaesthesia care unit (PACU), an expected average of 60 minutes.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Postoperative Residual Curarization</condition>
  <condition>Residual Neuromuscular Block</condition>
  <arm_group>
    <arm_group_label>Cisatracurium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Induction and maintaining of anaesthesia with Propofol. Analgesia either with Fentanyl or Fentanyl+Remifentanyl.
Cisatracurium (Nimbex):
initial dose: 0.2 mg/kg
maintaining dose: 0.1 mg/kg (repeated anytime TOF-count reaches 2 twitches)
At the end of the surgical operation, patients will be administered Neostigmine 0.04 mg/kg and Atropine 0.02 mg/kg.
Patients will be extubated with a TOF-Ratio of at least 0.90.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rocuronium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Induction and maintaining of anaesthesia with Propofol. Analgesia either with Fentanyl or Fentanyl+Remifentanyl
Rocuronium (Esmeron):
initial dose: 0.6 mg/kg
maintaining dose: 0.15 mg/kg (repeated anytime TOF-count reaches 2 twitches)
At the end of the surgical operation, patients will be administered Neostigmine 0.04 mg/kg and Atropine 0.02 mg/kg.
Patients will be extubated with a TOF-Ratio of at least 0.90.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cisatracurium</intervention_name>
    <description>Cisatracurium (Nimbex):
initial dose: 0.2 mg/kg
maintaining dose: 0.1 mg/kg (repeated anytime TOF-count reaches 2 twitches)</description>
    <arm_group_label>Cisatracurium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium</intervention_name>
    <description>Rocuronium (Esmeron):
initial dose: 0.6 mg/kg
maintaining dose: 0.15 mg/kg (repeated anytime TOF-count reaches 2 twitches)</description>
    <arm_group_label>Rocuronium</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  general anaesthesia with need to use of neuromuscular-blocking agents

          -  awakening and extubation of the patient in the operating room and permanence in the
             PACU for at least 60 minutes

          -  age 18-80

          -  surgical operations lasting at least 1 hour

          -  ASA class I-III

          -  possibility to apply TOF-monitoring with thumb-acceleromyography

          -  women of childbearing age not using contraceptives

          -  women of childbearing age using contraceptives

        Exclusion Criteria:

          -  subjects unable to give a valid consent

          -  patients in emergency situations

          -  patients not awakened and not extubated in the operating room

          -  age above 80 years or under 18 years

          -  surgical operations lasting less than an hour

          -  ASA class IV

          -  impossibility to apply and/or perform TOF-monitoring

          -  neuromuscular diseases

          -  intake of therapies interfering with the neuromuscular function

          -  patients having contraindications for either studied drug

          -  pregnant women

          -  women who are breast-feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlo Ori, Prof. M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Universit√† degli Studi di Padova - Azienda Ospedaliera di Padova</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paolo Feltracco, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera di Padova</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Padova</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 23, 2012</study_first_submitted>
  <study_first_submitted_qc>July 25, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2012</study_first_posted>
  <last_update_submitted>March 9, 2014</last_update_submitted>
  <last_update_submitted_qc>March 9, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera di Padova</investigator_affiliation>
    <investigator_full_name>Dr. Paolo Feltracco</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Postoperative residual curarization</keyword>
  <keyword>Residual neuromuscular block</keyword>
  <keyword>Complications</keyword>
  <keyword>Postoperative</keyword>
  <keyword>Neuromuscular function</keyword>
  <keyword>Neuromuscular block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delayed Emergence from Anesthesia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
    <mesh_term>Atracurium</mesh_term>
    <mesh_term>Cisatracurium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

